March 17, 2025

ADA symposium to equip dentists to be champions for overall health

The symposium will show how dental professionals can become leaders in the battle against chronic disease.

ADA News

March 17, 2025

Life’s Simple 7 Adherence: Constipation & Diarrhea Analysis

"As we move toward a more holistic approach to health care, integrating lifestyle modifications into clinical practice could lead to improved gastrointestinal health outcomes."

Conexiant

March 17, 2025

Neurostimulation Approved for Nonsurgical Back Pain

New ASPN guidelines provide evidence-based support for spinal cord stimulation in patients with chronic low back pain who aren't surgical candidates.

Conexiant

March 17, 2025

Statins Reduce HCC Risk in Liver Disease

New research shows statin therapy significantly lowers hepatocellular carcinoma and hepatic decompensation risk while improving fibrosis outcomes in chronic liver disease patients with elevated FIB-4 scores.

Conexiant

March 17, 2025

Incyte’s Povorcitinib Shows Mixed Phase 3 Results

Incyte's povorcitinib, an oral JAK1 inhibitor, demonstrates promising results in phase 3 trials for hidradenitis suppurativa, potentially offering a new alternative treatment option.

Reuters

March 17, 2025

Recipe for T2D: Poor Sleep Plus Gestational Diabetes

Women with gestational diabetes who snore regularly or sleep fewer than 6 hours per day may have twice the risk of developing type 2 diabetes.

Conexiant

March 14, 2025

HPV Vaccine Reduces Actinic Keratoses

VAXAK randomized trial demonstrates significant reduction in precancerous skin lesions following standard 9-valent alphapapillomavirus vaccination.

Conexiant

March 14, 2025

Probiotics May Cut Fever Time in Kids

Probiotic mixture reduces fever duration by 2 days in children with upper respiratory infections; triple-blind trial shows significant benefits with minimal side effects.

Conexiant

March 14, 2025

Incretin Drugs Linked to Gallbladder Disease Risk

Prescribers should be aware of the risk of gallbladder and biliary tract diseases when using incretin-based drugs in patients with T2D regardless of BMI status, study shows.

Conexiant